science PPP

We caught up with Henri Sant-Cassia, founding Director at The Conscious Fund, a global investor in early-stage ventures within psychedelic medicine, helping ...

We caught up John Maher, Chief Scientific Officer at Leucid Bio, a UK Biotechnology company focused on progressing novel CAR T therapies to improve treatment...

We caught up Alex Latyshev, Co-Founder and CEO at HIVE, a global network of next generation mental health centres specialising in psychedelic assisted psycho...

We caught up with Cosmo Feilding Mellen, Chief Executive Officer at Beckley Psytech Limited, a neuropharmaceutical company developing a pipeline of psychedel...

Our interview with Gareth Morinan, Chief Scientific Officer at Machine Medicine Technologies, which has developed an AI platform for the objective measuremen...

We caught up with Michael O’Rourke, Chief Executive Officer at Re-Vana Therapeutics, which is developing sustained release biologics and small molecule drugs...

We caught up with Victoria Norman, CEO & Founder at Signum Health, who provide Virtual health care services, powered by their own digital interface. The...

We caught up with Chris Ashton, Chief Commercial Officer and Chief Pharmacist at LYPHE GROUP, the UK leader in the reliable and seamless supply of...

We caught up with Alasdair Pettigrew, CEO at MeOmics, the global provider in Precision Psychiatry. The purpose of article series ‘Product | People | Potentia...

We caught up with Tess Isabelle Cosad, Co-Founder & CEO at Béa Fertility. Béa Fertility is the first clinically-validated, at-home fertility treatment, l...

We caught up with Henrik Hagemann, CEO and Co-Founder of Puraffinity. Puraffinity is a green technology company incorporated in 2015, focusing on designing s...

We caught up with Dave Llewellyn, CEO of DJS Antibodies, as part of ‘Product | People | Potential’. DJS Antibodies has developed HEPTAD, a novel...